While there is a huge opportunity for pharmaceutical and Healthcare companies to sell their products in emerging markets due to rising incomes, higher incidence of chronic and lifestyle diseases, better insurance coverage, and better patent protection regimes for drugs, major roadblocks such as lack of mature distribution networks, lower price points due to generics competition, and counterfeiting are leaving even the large companies struggling to handle the challenges from some of these less sophisticated markets. Local business partnerships and better understanding and responsiveness to cultural differences will be very important in determining the success in emerging markets.

ASSOCHAM in its quest to resolve these issues and create a fine link through global regulators and industry experts, and bring first hand information at the disposal are some of the objectives aimed through ASSOCHAM’s unique endeavour “GCT 2013 ? Challenges & Opportunities”

Participation Details
Due to the support of Department of Biotechnology, Government of India, ASSOCHAM wave off the Registration fees for GCT 2013; Generic Drugs, Clinical Trials & Technology Conference at Hotel Metropole, Ahmedabad on 30th April 2013.

read more